Literature DB >> 23542006

A homology model of HIV-1 integrase and analysis of mutations designed to test the model.

Barry C Johnson1, Mathieu Métifiot, Andrea Ferris, Yves Pommier, Stephen H Hughes.   

Abstract

Although there are structures of the different domains of human immunodeficiency virus type 1 (HIV-1) integrase (IN), there is no structure of the entire protein. The recently determined crystal structures of the prototype foamy virus (PFV) IN tetramer, in complexes with viral DNA, led to the generation of models of full-length HIV-1 IN. These models were generated, in part, by superimposing the structures of the domains of HIV-1 IN onto the structure of full-length PFV IN. We developed a model for HIV-1 IN-based solely on its sequence alignment with PFV IN-that differs in several ways from the previous models. Specifically, in our model, the junction between the catalytic core domain and C-terminal domain adopts a helix-loop-helix motif that is similar to the corresponding segment of PFV IN and differs from the crystal structures of these two HIV-1 IN domains. The alignment of residues in the C-terminal domain also differs from the previous models. Our model can be used to explain the phenotype of previously published HIV-1 IN mutants. We made additional mutants, and the behavior of these new mutants provides additional support for the model.
Copyright © 2013. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23542006      PMCID: PMC6775779          DOI: 10.1016/j.jmb.2013.03.027

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  51 in total

1.  Biochemical and pharmacological analyses of HIV-1 integrase flexible loop mutants resistant to raltegravir.

Authors:  Mathieu Métifiot; Kasthuraiah Maddali; Alena Naumova; Xuemin Zhang; Christophe Marchand; Yves Pommier
Journal:  Biochemistry       Date:  2010-05-04       Impact factor: 3.162

2.  Molecular mechanisms by which human immunodeficiency virus type 1 integrase stimulates the early steps of reverse transcription.

Authors:  Charles W Dobard; Marisa S Briones; Samson A Chow
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

3.  Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium.

Authors:  Y Goldgur; F Dyda; A B Hickman; T M Jenkins; R Craigie; D R Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

4.  Identification of amino acids in HIV-1 and avian sarcoma virus integrase subsites required for specific recognition of the long terminal repeat Ends.

Authors:  Aiping Chen; Irene T Weber; Robert W Harrison; Jonathan Leis
Journal:  J Biol Chem       Date:  2005-11-18       Impact factor: 5.157

5.  Molecular dynamics approaches estimate the binding energy of HIV-1 integrase inhibitors and correlate with in vitro activity.

Authors:  Barry C Johnson; Mathieu Métifiot; Yves Pommier; Stephen H Hughes
Journal:  Antimicrob Agents Chemother       Date:  2011-10-28       Impact factor: 5.191

6.  Structure-based modeling of the functional HIV-1 intasome and its inhibition.

Authors:  Lavanya Krishnan; Xiang Li; Hema L Naraharisetty; Stephen Hare; Peter Cherepanov; Alan Engelman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

7.  Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrases.

Authors:  S Maignan; J P Guilloteau; Q Zhou-Liu; C Clément-Mella; V Mikol
Journal:  J Mol Biol       Date:  1998-09-18       Impact factor: 5.469

8.  Characterization of the minimal DNA-binding domain of the HIV integrase protein.

Authors:  R A Lutzke; C Vink; R H Plasterk
Journal:  Nucleic Acids Res       Date:  1994-10-11       Impact factor: 16.971

9.  Structural basis for HIV-1 DNA integration in the human genome, role of the LEDGF/P75 cofactor.

Authors:  Fabrice Michel; Corinne Crucifix; Florence Granger; Sylvia Eiler; Jean-François Mouscadet; Sergei Korolev; Julia Agapkina; Rustam Ziganshin; Marina Gottikh; Alexis Nazabal; Stéphane Emiliani; Richard Benarous; Dino Moras; Patrick Schultz; Marc Ruff
Journal:  EMBO J       Date:  2009-02-19       Impact factor: 11.598

10.  DNA bending creates favored sites for retroviral integration: an explanation for preferred insertion sites in nucleosomes.

Authors:  H P Müller; H E Varmus
Journal:  EMBO J       Date:  1994-10-03       Impact factor: 11.598

View more
  30 in total

1.  Distribution and Redistribution of HIV-1 Nucleocapsid Protein in Immature, Mature, and Integrase-Inhibited Virions: a Role for Integrase in Maturation.

Authors:  Juan Fontana; Kellie A Jurado; Naiqian Cheng; Ngoc L Ly; James R Fuchs; Robert J Gorelick; Alan N Engelman; Alasdair C Steven
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

2.  Allosteric HIV-1 Integrase Inhibitors Lead to Premature Degradation of the Viral RNA Genome and Integrase in Target Cells.

Authors:  Michaela K Madison; Dana Q Lawson; Jennifer Elliott; Ayşe Naz Ozantürk; Pratibha C Koneru; Dana Townsend; Manel Errando; Mamuka Kvaratskhelia; Sebla B Kutluay
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

3.  A critical role of the C-terminal segment for allosteric inhibitor-induced aberrant multimerization of HIV-1 integrase.

Authors:  Nikoloz Shkriabai; Venkatasubramanian Dharmarajan; Alison Slaughter; Jacques J Kessl; Ross C Larue; Lei Feng; James R Fuchs; Patrick R Griffin; Mamuka Kvaratskhelia
Journal:  J Biol Chem       Date:  2014-08-12       Impact factor: 5.157

Review 4.  Structural Insights on Retroviral DNA Integration: Learning from Foamy Viruses.

Authors:  Ga-Eun Lee; Eric Mauro; Vincent Parissi; Cha-Gyun Shin; Paul Lesbats
Journal:  Viruses       Date:  2019-08-22       Impact factor: 5.048

5.  Resistance to pyridine-based inhibitor KF116 reveals an unexpected role of integrase in HIV-1 Gag-Pol polyprotein proteolytic processing.

Authors:  Ashley C Hoyte; Augusta V Jamin; Pratibha C Koneru; Matthew J Kobe; Ross C Larue; James R Fuchs; Alan N Engelman; Mamuka Kvaratskhelia
Journal:  J Biol Chem       Date:  2017-09-28       Impact factor: 5.157

6.  Retroviral Integrase Structure and DNA Recombination Mechanism.

Authors:  Alan Engelman; Peter Cherepanov
Journal:  Microbiol Spectr       Date:  2014

7.  Cryo-EM structures and atomic model of the HIV-1 strand transfer complex intasome.

Authors:  Dario Oliveira Passos; Min Li; Renbin Yang; Stephanie V Rebensburg; Rodolfo Ghirlando; Youngmin Jeon; Nikoloz Shkriabai; Mamuka Kvaratskhelia; Robert Craigie; Dmitry Lyumkis
Journal:  Science       Date:  2017-01-06       Impact factor: 47.728

8.  C-Terminal Domain of Integrase Binds between the Two Active Sites.

Authors:  Victoria A Roberts
Journal:  J Chem Theory Comput       Date:  2015-08-06       Impact factor: 6.006

9.  Selectivity for strand-transfer over 3'-processing and susceptibility to clinical resistance of HIV-1 integrase inhibitors are driven by key enzyme-DNA interactions in the active site.

Authors:  Mathieu Métifiot; Barry C Johnson; Evgeny Kiselev; Laura Marler; Xue Zhi Zhao; Terrence R Burke; Christophe Marchand; Stephen H Hughes; Yves Pommier
Journal:  Nucleic Acids Res       Date:  2016-07-01       Impact factor: 16.971

Review 10.  Cellular and molecular mechanisms of HIV-1 integration targeting.

Authors:  Alan N Engelman; Parmit K Singh
Journal:  Cell Mol Life Sci       Date:  2018-02-07       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.